Barclays PLC
NYSE:BCSBanks - Diversified
+$0.12 today
- Market cap
- $72.23B
- Beta
- 0.90
- P/E (TTM)
- 9.5
- EPS (TTM)
- $0.53
- Dividend yield
- 1.72%
Volume 4.84M
Average 6.73M
BCS EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Barclays PLCNYSE: BCS
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA grows, but more slowly than its trailing trend
Q3 FY2026 EBITDA of £2.3B rose 10.6% year over year, behind the +16.3% change in trailing-twelve-month EBITDA. Sequentially, it fell 29.7% from the prior quarter. Over 3 fiscal years it compounded at +7.5% a year.
Context
- EBITDA amounted to 21.4% of revenue in FY2025, up 4.0 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 9 analysts of £13.41B (+23.1%) for the fiscal year ending Dec 2026, a step up from the +9.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- £2.3B-29.7% QoQ
- Last fiscal yearDec 2025
- £10.9B+9.6% YoY
- LTMSep 2026
- £10.29B+16.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +10.6% | +26.4% | +15.8 pp |
| 1 year | +9.6% | +23.1% | +13.5 pp |
| 3-year CAGR | +7.5% | +19.2% | +11.6 pp |
| 5-year CAGR | +15.2% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
GBP · from the income statement
- Latest · FY2025
- 10.9B GBP
- Year-over-year change
- +9.6%
- 4-year CAGR
- +2.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.9B | +9.6% |
| FY2024 | 2024-12-31 | 9.94B | +20.6% |
| FY2023 | 2023-12-31 | 8.24B | -5.9% |
| FY2022 | 2022-12-31 | 8.76B | -11.2% |
| FY2021 | 2021-12-31 | 9.87B | — |
EBITDA vs competitors
How BCS compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +16.3% is the 5th highest of 9, against a peer median of +15.7%.
- EBITDA amounts to 33.4% of revenue for BCS, versus a peer median of 23.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $92.28B USD | +13.5% | +15.2% | 30.6% | |
| LTM Sep 2026 | $45.43B USD | +31.1% | +6.7% | 23.3% | |
| LTM Jun 2026 | $39.72B USD | +38.0% | +18.5% | 29.5% | |
| LTM Jul 2026 | CA$32.02B CAD | +17.8% | +8.1% | 22.4% | |
| LTM Sep 2026 | $30.03B USD | +24.6% | +1.6% | 19.5% | |
| LTM Jul 2026 | CA$22.22B CAD | -15.1% | +4.1% | 19.7% | |
| LTM Jun 2026 | €21.15B EUR | -5.6% | +6.2% | 23.4% | |
| LTM Jun 2026 | €18.57B EUR | +5.7% | +15.2% | 38.0% | |
| LTM Sep 2026 | £10.29B GBP | +16.3% | +7.5% | 33.4% | |
| Peer median (excluding BCS) | — | +15.7% | +7.4% | 23.4% | |
Competitors are the stored peer set for BCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 25.12B | 33.3B | 49.77B | 57.02B | 50.83B |
| Cost of Revenue | 3.17B | 9.75B | 23.91B | 27.96B | 21.69B |
| Gross Profit | 21.95B | 23.55B | 25.86B | 29.05B | 29.14B |
| Gross Margin | 87.4% | 70.7% | 52.0% | 51.0% | 57.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.97B | 10.95B | 11.77B | 11.94B | 2.73B |
| Operating Expenses | 13.76B | 16.52B | 19.4B | 20.81B | 20B |
| Depreciation & Amortization | 1.67B | 1.72B | 1.78B | 1.7B | 1.76B |
| EBITDA | 9.87B | 8.76B | 8.24B | 9.94B | 10.9B |
| EBITDA Margin | 39.3% | 26.3% | 16.6% | 17.4% | 21.4% |
| Operating Income | 8.19B | 7.04B | 6.45B | 8.28B | 9.14B |
| Operating Margin | 32.6% | 21.1% | 13.0% | 14.5% | 18.0% |
| Interest Income | 11.24B | 19.21B | 34.5B | 39.14B | 36.19B |
| Interest Expense | 3.17B | 8.56B | 22B | 25.93B | 21.69B |
| Other Income / Expenses | 0 | (6.03M) | 8.85M | (37.78M) | 0 |
| Income Before Tax | 8.19B | 7.04B | 6.46B | 8.24B | 9.14B |
| Pre-Tax Margin | 32.6% | 21.1% | 13.0% | 14.5% | 18.0% |
| Income Tax Expense | 1.14B | 1.04B | 1.21B | 1.79B | 1.93B |
| Net Income | 7.01B | 5.95B | 5.17B | 6.44B | 7.17B |
| Net Margin | 27.9% | 17.9% | 10.4% | 11.3% | 14.1% |
| EPS (Basic) | 1.48 | 1.24 | 1.12 | 1.44 | 1.80 |
| EPS (Diluted) | 1.44 | 1.20 | 1.08 | 1.40 | 1.80 |
| Weighted Avg Shares | 4.25B | 4.08B | 3.86B | 3.69B | 3.45B |
| Weighted Avg Shares (Diluted) | 4.36B | 4.22B | 3.97B | 3.82B | 3.45B |
Barclays PLC
NYSE:BCS
Intrinsic Alpha fair value
Locked
Current Price
$21.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.